International Stem Cell Corporation’s Human Parthenogenetic Stem Cells To Be Used In Germany In The Development Of Treatments For Neural Disease

Monday, March 3rd, 2008

International Stem Cell Corporation (OTCBB:ISCO) announced that its human parthenogenetic stem cell lines will be used in Germany in studies aimed at creating specific cell types to treat human neural diseases such as Parkinson's disease. The work will be headed by Dr. Albrecht Mueller of the University of Wuerzburg, Wuerzburg, Germany ...

Smoking’s Effects On Genes May Play A Role In Lung Cancer Development And Survival

Tuesday, February 26th, 2008

Smoking plays a role in lung cancer development and now scientists have shown that smoking also affects the way genes are expressed, leading to alterations in cell division and regulation of immune response. Notably, some of the changes in gene expression persisted in people who had quit smoking many years ...

Asian Development Bank President Kuroda Launches $20M Program Aimed At Reducing Spread Of HIV/AIDS Among Youth In Vietnam

Monday, February 25th, 2008

During a visit to Hanoi, Vietnam, on Wednesday, Asian Development Bank President Haruhiko Kuroda launched a $20 million program aimed at reducing the spread of HIV among young people in the country, AFP/Google.com reports (AFP/Google.com, 2/20). Kuroda met with members of the Youth Advisory Group to discuss strategies to implement the ...

Sequenom Announces Key Milestone In Development Of Noninvasive Prenatal Down Syndrome Test

Friday, February 22nd, 2008

Sequenom, Inc. (NASDAQ:SQNM) announced a significant step in the development of a noninvasive test for Trisomy 21, Down syndrome, that will incorporate multiple RNA fetal markers, including the PLAC4 gene as previously published by Dr. Dennis Lo, Chinese Hong Kong University. In preliminary studies, more than 100 clinical plasma specimens of ...

Open Source As A Development Tool: Global Consortium Launches Study

Wednesday, February 20th, 2008

The European Union has awarded a 703,000 euros(US$ 1 million) grant to a consortium of 11 organizations to explore the use of Free/Libre/Open Source Software (FLOSS) as a development tool. Dubbed FLOSSInclude and funded under the EU's 7th Framework Programme, the two year project will be carried out by a project ...

ProCure Treatment Centers Teams With University Of Pennsylvania To Advance Proton Therapy Training, Research And Development

Tuesday, February 19th, 2008

ProCure Treatment Centers, Inc. and the University of Pennsylvania's Roberts Proton Therapy Center announced an agreement that will provide advanced training programs and accredit medical professionals in proton therapy - an alternative to conventional radiation therapy that avoids many of the side effects inherent in treatment. The agreement focuses on ...

U.S. HIV/AIDS, Development Work In Africa ‘Wise Exercise Of American Influence,’ Bush Says

Tuesday, February 19th, 2008

The U.S. effort to fight HIV/AIDS in Africa is "work of healing and redemption" and is a "wise exercise of American influence," President Bush said Thursday during a speech at the Smithsonian National Museum of African Art in Washington, D.C., USA Today reports. "The changes taking place in Africa don't ...

Brendan Technologies, Inc. Delivers New Analysis Software To Big Pharma That Offers ”Quantum Leap” For Drug Development Testing

Monday, February 18th, 2008

Brendan Technologies, Inc. (OTCBB:BDTE.OB) has begun placing a pre-release version of its new assay analysis software in several big pharma companies. The software, STATLIA(R) Quantum, offers a "quantum leap" advancement in analysis software for the analysis and processing of immunoassay and bioassay testing technologies, which are critical to the drug ...

New Finding May Help Explain Development Of Preeclampsia

Saturday, February 9th, 2008

In a study of pregnant women, those with pregnancy-induced high blood pressure were found to have higher levels of a peptide that raises blood pressure in the pieces of tissue linking mother and fetus, according to researchers at Wake Forest University Baptist Medical Center. The finding, reported online in the ...